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RESEARCH ARTICLE
Patient satisfaction after auditory implant surgery: ten-year experience from a
single implanting unit center
Simonetta Monini, Alessandra Bianchi, Rita Talamonti, Francesca Atturo, Chiara Filippi and Maurizio Barbara
NESMOS Department, ENT Clinic, Medicine and Psychology, Sapienza University, Rome, Italy
ABSTRACT
Conclusions: The satisfaction rate of the subjects with an auditory implant appears strictly related to
the resulting auditory improvement, and the surgical variables would play a prevailing role in respect
to the esthetic factors.
Objectives: To assess the rate of satisfaction in subjects who underwent the surgical application of an
auditory device at a single Implanting Center Unit.
Method: A series of validated questionnaires has been administered to subjects who underwent the
surgical application of different auditory devices. The Glasgow Benefit Inventory (GBI), the Visual
Analog Scale (VAS), and the Abbreviated Profile of Hearing Aid Benefit (APHAB) have been used to
compare the implanted situation with the hearing-aided one; a percutaneous bone conductive implant
(pBCI) with an active middle ear implant (AMEI) on the round window in mixed hearing loss; and an
invisible, fully-implantable device with a frankly and bulky semi-implantable device.
Results: The mean GBI scores were higher in Vibrant Soundbridge (VSB)VR and BonebridgeVR subjects,
without significant differences among the various devices. The mean VAS score increased for all the
devices in comparison with the conventional hearing aid. The mean APHAB score was similarly better
in the implanted condition as total and partial scores.
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Introduction
Hearing loss represents a condition that may certainly
impair the quality-of-life. Although most of the subjects pre-
senting with a moderate-to-severe hearing loss can usually
benefit from a conventional hearing aid (cHA), a relevant
number of them are shown to be poorly compliant to this
type of solution due to various reasons that also include
esthetic and cosmetic problems, social stigma, etc. In add-
ition, cHA may also carry some important limitations, such
as the impossibility to wear them during some physical
activities, in cases of water contact, in the presence of ear
pathology, and in subjects with inadequate manual skill. For
the above-mentioned reasons, it has been reported that only
23% of potential users really benefit from cHA amplification
and that only 58% of them regularly use it with satisfaction
[1,2].
In order to avoid or minimize these adverse factors, espe-
cially when the ear is affected by an inflammatory pathology,
different surgically implantable devices could be adopted in
the form of percutaneous or transcutaneous Bone
Conduction Implant (BCI), and partially- or totally-implant-
able Active Middle Ear Implant (AMEI) [3].
BCI have been proposed for the auditory rehabilitation of
conductive and mixed hearing loss, with great benefit for
the implanted subjects. The first validated study on BCI’s
quality-of-life has shown an overall improvement, in
particular in the presence of ear malformations or open
mastoid cavities [4]. Potential disadvantages for a percutan-
eous BCI (pBCI) application are a poor cochlear reserve,
limitations during aquatic activity, and, mostly, the risk of
skin infections, that has, however, been decreased by the
adoption of new surgical modalities [5]. On the other hand,
the pBCI is certainly one of the most visible among all the
implantable auditory devices, due the presence of a screw
behind the auricle and the still bulky design of the external
component that is not easily hidden, for instance, on a mal-
e’s head. In a recent survey among pBCI users, it has how-
ever been shown that the European population is likely to
favorably accept the device when accurate pre-operative
selection and counseling are carried out [6].
Apart from the post-operative audiological evaluation in
terms of hearing improvement, many Implanting Centers
are also implementing the overall assessment of their effi-
cacy by administering standardized questionnaires, in order
to get evidence of the effects that the implanted devices have
on patients’ quality-of-life. In this regard, most of the
adopted questionnaires are the same as used for the evalu-
ation of benefit with cHA, one of the main targets being the
comparison of the performance between the auditory
implant and the cHA.
The pBCI systems have undergone several investigations
in this regard, counting on long-term follow-up evaluations
due to their early introduction in the clinical practice, that
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have shown that, owing to its overall acceptance level, they
remain the treatment of choice when indicated appropriate
[7–9]. As far as AMEI are concerned, a few studies have
been performed on one semi-implantable device, the VSBVR ,
and on one fully implantable device, the EsteemVR . The VSB
is a partially-implantable electromagnetic device, whose
actuator allows a prevalent amplification at the high fre-
quencies, when applied either on the ossicular chain (sen-
sorineural hearing loss) or on the round window membrane
in case of mixed hearing loss (RW-VSB). For this type of
implant, some studies have focused on the long-term func-
tional outcome and showed a global satisfaction and positive
benefits in the achievement of decreased difficulty in various
listening environments [10,11]. Other reports have shown an
improvement in performance and a large preference in
respect to conventional hearing aids, along with an increased
quality-of-life also for leaving the external ear canal non-
occluded and the per-auricular region free [12].
As far as the totally implantable middle ear device
EsteemVR is concerned, only a few reports have regarded the
outcome for quality-of-life. The EsteemVR , an invisible piezo-
electric middle ear implant, has been proposed as a possible
rehabilitative procedure for moderate and severe SNHL,
especially in patients who are unsatisfied cHA-wearers such
as in the young population that suffers from the negative
symbolic image associated to a HA [13]. With the EsteemVR ,
one of the most important factors for patient satisfaction is
surely the possibility to use it every day and without inter-
ruptions (overnight use) [14,15].
The BonebridgeVR implant is a semi-implantable, transcu-
taneous BCI device, recently introduced in clinical practice,
that is composed of an internal, implantable part, completely
under the skin, coupled to an external audio-processor. Its
use has been associated to an improvement of quality-of-life
regarding social and physical health in patients with con-
ductive and mixed hearing loss [16,17].
To our knowledge, no study has previously reported on
the satisfaction outcome after implantation of different
implantable devices taken altogether. The present study has
been designed for this purpose by using standardized ques-
tionnaires on a cohort of subjects affected by different type
of hearing loss and who, accordingly, have received the
most appropriate auditory device. Despite the heterogeneity
of the sample and different numbers for each device, that
certainly could represent an objective limitation of the study,
some interesting remarks could be drawn, in particular
when comparing:
 cHA-aided vs the implant-aided situations;
 pBCI vs an AMEI in mixed hearing loss; and
 the two potentially extreme aesthetic situations, such as a
percutaneous BCI against an invisible, totally implantable
device, such as the EsteemVR .
Materials and methods
From January 2005 to November 2015, 130 subjects under-
went an auditory surgical rehabilitation with different types
and modalities of implantable devices at a tertiary care
University Hospital and were planned to be included in a
satisfaction survey. Sixty-three of them were, however,
excluded for the following reasons: deceased (n¼ 3), lost to
follow-up (n¼ 21), short, less than 1 year follow-up (n¼ 5),
unavailable at the question time (n¼ 16), explant of the
device (n¼ 11), processors temporarily on repair (n¼ 2), or
insufficient number of cases for single device (MaxumVR ,
Ototronix, Saint Paul, MN; Retro-XVR , Auric, Rheine,
Germany; and CodacsVR , Cochlear, Melbourne, Australia).
Therefore, the present evaluation has taken into account 67
implanted patients (33 males and 34 females, age ranging
from 24–88 years, mean¼ 60.54 years) that were further dis-
tinguished in: 27 percutaneous Bone Conduction Implants
or pBCI (either BAHAVR , Cochlear, Melbourne, Australia; or
PONTOVR , Oticonmedical, Askim, Sweden), 21 presenting
with a conductive or mixed hearing loss and six with single
sided deafness; four transcutaneous BCI (BonebridgeVR ,
Medel, Innsbruck, Austria) with a conductive or mixed hear-
ing loss, 10 Vibrant SoundbridgeVR (Medel) with mixed hear-
ing loss and 26 EsteemVR (Envoymedical, Minneapolis, MN)
with sensorineural hearing loss (Table 1). All the patients
had previously been rehabilitated with different types of
cHA for a minimum of 6 months. The study has taken into
consideration patients that had been implanted at least
1 year before the present survey, in order to allow several
fitting sessions for an optimal individual adaptation of
each device.
Different questionnaires were administered to each
implanted subject to obtain information on their subjective
perception of sound, on health status, esthetic impact, and
overall quality-of-life. Each questionnaire has been adminis-
tered during a check-up visit after all the subjects signed a
specific informed consent, and the study was performed in
accordance with the Helsinki Declaration principles.
The standardized questionnaires were:
1. General Glasgow Benefit Inventory (Italian standardized
version) [18]. This is a general questionnaire that aims
to evaluate post-surgical quality-of-life. It is based on 18
questions that assess health changes after surgery (12 on
Table 1. Demographics of the study sample.
Device n Males Females Hearing loss Mean age, years
pBCI 27 10 17 21 CHL and MHL; 6 SSD 62.88 (36.92–80.03)
VIBRANT SOUNDBRIDGE 10 4 6 MHL 63.88 (43.83–72.06)
BONEBRIDGE 4 4 6 CHL 67.35 (62.78–77.49)
ESTEEM 26 16 10 SNHL 48.06 (24.39–88.69)
pBCI: percutaneous bone conductive implant; CHL: conductive hearing loss; MHL: mixed hearing loss; SNHL: sensorineural hearing
loss; SSD: single-sided deafness.
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general health, three on physical health, three on social
health). To each question, five answers are possible,
with a score ranging from 1–5, so that the total score
will be allocated between 100 to þ100 (from the worst
to the best one), calculated through a simple mathemat-
ical formula (the total score is divided by the number of
questions, subtracting 3 and multiplying by 50).
2. Visual Analog Scale (VAS). The VAS scale (from 0–10)
has been used to measure subjective judgment in rela-
tion to both quality of perceived sound and to quality-
of-life, by comparing the pre-implant (conventional
hearing aided: cHA-aided) with the post-implant (acti-
vated implant: I-aided) situation. In order to increase
the sensitivity of the test, the results have also been dis-
tinguished according to the rate value, considering a
score >6 as good, and >8 as excellent.
3. Abbreviated Profile of Hearing Aid Benefit (APHAB)
(Italian standardized version) [19]. This questionnaire is
generally used to quantify everyday life problems associ-
ated with hearing loss and to evaluate the reduction of
disability that can be achieved with a hearing aid. In the
present study, the APHAB questionnaire has been used
to compare the I-aided situation with the cHA-aided
one, giving the patients the possibility to describe the
frequency of auditory problems with or without the
device.
The questionnaire comprises 24 items divided into four
sub-domains:
 Ease of Communication (EC): communication skills
under relatively favorable conditions.
 Background Noise (BN): communication in settings
with high background noise levels.
 Reverberation (RV): speech understanding in moder-
ately reverberant rooms.
 Aversiveness (AV): the negative reactions to the
environmental sound.
Each domain is composed of six questions. The answer
to each item considers seven possibilities of changing, in
percent from 1% to 99%, with intermediate scores of 12%,
25%, 50%, 75%, and 87%. The partial domain score has
been derived from the average percentage of the six ques-
tions in the single domain, while the total score has been
derived from the mean of the total questions of all the sub-
domains. The eventual partial or total score reduction, from
the cHA-aided to the I-aided situation, would show the pos-
sible and probable gain and displays the benefit of the
implanted device.
A Student’s t-test (p< .05) has been used for statistical
analysis to evaluate the difference among the questionnaire
scores recorded in different devices, and between the
unaided and the aided situations in each device, only in the
APHAB and VAS for quality of sound.
Results
Demographic data relative to the study sample are described
in Table 1.
General Glasgow benefit inventory (GBI)
The mean total GBI score recorded for each device is shown
in Figure 1(A) and was 22.92 for pBCI; 19.93 for EsteemVR ;
36.47 for VSB, and 35.21 for BonebridgeVR . A significant dif-
ference was found only between VSB and EsteemVR , in favor
of the former (p¼ .028).
The mean partial scores recorded for each device is
shown in Figure 1(B). For ‘social health’, it was 40 in
BonebridgeVR 47 in VSB; 18 in pBCI; and 24 in EsteemVR . For
‘general health’, it was 30 in BonebridgeVR , 8 in VSB, 9 in
pBCI, and 2 in EsteemVR . For ‘physical health’, it was 22 in
BonebridgeVR , 28 in VSB; 50 in pBCI; and 34 in EsteemVR .
For ‘social health’, a significantly better score has been
recorded for pBCI over the other implants (p< .05); for
‘general health’, a significantly better score has been
recorded for VSB vs EsteemVR (p< .05); for ‘physical health’,
a significantly better score has been recorded for the pBCI
vs the EsteemVR (p< .05).
Visual analog scale (VAS)
Quality of sound
The mean VAS score in the different devices, in comparison
with the conventionally-hearing aided (cHA-aided) condi-
tion, is presented in Figure 2. In pBCI, it has increased from
5.3 to 7.9; in the EsteemVR from 4.9 to 7.1; in VSB from 5.8
to 8.4; and in BonebridgeVR from 5.5 to 8.1.
For all the devices, the comparison between cHA-aided
and I-aided scores showed a significant difference in favor
of the former (p< .05), whilst no statistical differences
(p> .05) in the gain for the perceived quality of sound had
been assessed among them.
When considering the VAS score >8, a significant differ-
ence was only found in favor of the VBS vs the EsteemVR
(p¼ .0128).
Quality-of-life
The mean VAS score in the different devices is reported in
Figure 2. When considering VAS >6, values were 10 for the
EsteemVR and BonebridgeVR , 9 for VSB, and 8 for pBCI.
When considering VAS >8, values were 10 for the EsteemVR ,
3 for VSB, 2.5 for BonebridgeVR , and 1 for pBCI.
Abbreviated profile of hearing aid benefit (APHAB)
The APHAB score in conventionally aided (cHA-aided) and
I-aided situation is presented in Figure 3. The mean total
percentage score was 58% in the cHA-aided condition and
24% in the pBCI-aided; 60% in the cHA-aided condition
and 31% in the Esteem-aided; 64% in cHA-aided condition
and 29% in the VSB-aided; and 58% in the cHA-aided con-
dition and 23% in the Bonebridge-aided. The comparison
between the cHA-aided and the I-aided condition showed
significant differences for each device (p< .05). The APHAB
scores for single sub-domain, in the cHA-aided and I-aided
situations are summarized in Figure 3. For all the devices,
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Figure 2. Visual Analog Scale (VAS) for quality of sound, by comparing the conventionally-aided (cHA-aided) vs the activated implant (I-aided) conditions. A better
score is recorded in the I-aided setting, with score for BCI statistically better than for Esteem (p< .05). VAS for quality-of-life. Percentage of distribution of patients
who reported VAS values over 6 and over 8. When considering a good appreciation, no significant differences are seen among all the devices; when considering an
optimal appreciation, the Esteem device’s values appear significantly much better than the other devices.
General Glasgow Benefit Inventory
Total Score
Partial Scores
BONEBRIDGE
VSB
pBCI
ESTEEM
Score
GENERAL HEALTH
PHYSICAL HEALTH
SOCIAL HEALTH
35.21
36.47
22.92
19.93
−100 −60 −20 20 60 100
−100. −60. −20. 20. 60. 100.
BONEBRIDGE
VSB
pBCI
ESTEEM
score
Figure 1. Glasgow Benefit Inventory (GBI) score, which explores the surgical impact on life. (A) Total score. A significant difference between VSB and Esteem has
been shown (p¼ .028). (B) Evaluation of the GBI partial scores (social health, general health, and physical health). For ‘social health’, a significantly better score has
been recorded for pBCI over the other implants (p< .05); for ‘general health’, a significantly better score has been recorded for Vibrant Soundbridge (VSB) vs
Esteem. (p< .05); for ‘physical health’, a significantly better score has been recorded for the pBCI vs the Esteem (p< .05). General health (black bar); Physical health
(grey bar); Social health (white bar). VSB, Vibrant Soundbridge; pBCI, percutaneous bone conductive Implants.
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an APHAB positive gain has been recorded between the
cHA and I-aided situation, in all the domains except for the
aversiveness domain in which a negative gain was always
found. The largest improvement was reached in pBCI
patients for the BN domain and in BonebridgeVR patients for
the RV domain. In all the devices the same gain was
observed for the EC domain. The comparison between I-
aided and cHA-aided situations for each domain showed a
significant difference (p< .05), except for AV in VSB and
BN in BonebridgeVR .
pBCI vs round window vibrant soundbridge (RW-VSB) in
mixed hearing loss
VAS quality of sound
A significant improvement was found when comparing the
cHA-aided vs the I-aided conditions, both for BCI (p¼ .013)
and for RW-VSB (p¼ .000 039) (Figure 4). No statistically
significant difference between the two devices was found.
Aphab The total and partial scores recorded for pBCI and
RW-VSB were similar, without significant differences
(Figure 5).
Fully-implantable esteem vs pBCI
VAS quality of sound
In both EsteemVR and pBCI, a significant better score was
found in comparison with the cHA-aided condition, without
significant differences between them (Figure 6).
VAS quality-of-life
For values over 6, a better score was found in both situa-
tions (EsteemVR ¼ 10; pBCI¼ 8). For values over 8, the
EsteemVR maintained the same value, i.e. 10, whilst the score
for pBCI dropped to 1.5 (Figure 6).
APHAB The total score showed a statistically significant
improvement, both for the EsteemVR (p¼ .000 000 000 58)
and the pBCI (p¼ .000 000 010). The partial scores recorded
an improvement in all the sub-domains but for aversiveness.
A statistically significant higher score was recorded for pBCI
in the reverberation sub-domain (Figure 7).
Discussion
Particular attention has recently been focused on the neces-
sity to evaluate any type of auditory rehabilitation, not only
APHAB SCORE: BENEFIT OF THE IMPLANTED DEVICE
DEVICE % OF BENEFIT
BONEBRIDGE 54,34%
VSB 54,30%
pBCI 54,86%
ESTEEM 46,18%
TOTAL SCORE
PARTIAL SCORES
50%
−1315%
26% 43%60%
−813%
76% 64%57%
−1189%
77% 56%35%
−1093%
78% 77%
BN AV EC RV
ESTEEM
BCI
VSB
BONEBRIDGE
60.4 58.
64.4
57.6
31.4
24.4
29.
23.4
0.
25.
50.
75.
100.
ESTEEM pBCI VSB BONEBRIDGE
%
APHAB
cHA-aided I-aided
Figure 3. Upper row: Total APHAB score for the assessment of benefit of the implanted device in cHA-aided vs I-aided conditions. For all the devices a statistically
significant improvement has been recorded in comparison with the cHA-aided situation, without any significance among the devices themselves (p> .05). A high
percentage of benefit is shown in all the devices. Lower row: APHAB gain for each device in the different sub-domains. In all the devices, ‘aversiveness’ gave nega-
tive values. Bonebridge reached the highest value for reverberation and percutaneous BCI for background noise. BN: background noise; AV: aversiveness; EC: ease
of communication; RV: reverberation.
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in terms of auditory improvement, but also as patients’ com-
pliance to wear, for instance, a conventional hearing aid
(cHA), with their subjective judgment on benefit and satis-
faction. For this purpose, specific questionnaires have been
available for scoring the different stages of cHA rehabilita-
tion, from selection, candidature, hearing aid fitting, and
adaptation.
When the semi- and totally implantable hearing devices
have become available and started to be applied in properly
selected cases, a similar approach has been followed, by
adopting new questionnaires that would specifically take
into consideration the surgical issues.
The present study has considered a cohort of implanted
subjects taken from a larger group that has undergone dif-
ferent types of procedures at the same Implanting Center.
The study group was eventually composed of 67 subjects,
while the rest of the subjects were not included for different
reasons. While some of these reasons, such as death
5.25
5.75
7.63
9.13
0
3
5
8
10
RW-VSBpBCI
sc
or
e
VAS QUALITY OF SOUND IN MIXED HEARING LOSS
cHA-aided
I-aided
Figure 4. VAS for quality of sound in mixed hearing loss (mean bone conduction threshold <40 dB), comparing percutaneous BCI (eight subjects) vs round
window vibroplasty (eight subjects). A significant improvement was recorded when comparing the cHA-aided vs the I-aided situations (pBCI: p¼ .013; RW-VSB:
p¼ .000 039).
0.
25.
50.
75.
100.
pBCI RW-VSB
%
ch-AIDED
I-AIDED
APHAB IN MIXED HEARING LOSS
58%
−899%
72% 69%61%
−1489%
81% 64%
RVECAVBN
BCI VSB
Total score Paral scores
Figure 5. APHAB in mixed hearing loss (BC threshold <40 dB), comparing pBCI (eight patients) vs RW-VSB (eight patients). The I-aided condition allowed a signifi-
cant improvement of the score, whilst no difference was found between the two implanting procedures. pBCI: percutaneous Bone Conduction Implants; RW-VSB:
Round window Vibrant Soundbridge.
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(three cases), unavailability at the question time (16 cases),
processor under repair (three cases), short follow-up (six-
cases), inadequate amount of single implant (five cases), and
lost to follow-up (21 cases) would not have represented a
biasing factor for the analysis, those who were explanted
(11 cases) could certainly represent a group with an at least
not favorable attitude towards the received surgical auditory
rehabilitation, although the explantation was not always
ensuing a totally negative experience. For instance, four of
the five subjects who had received a RetroXVR device, before
the advent of the open fitting hearing aids, preferred to shift
to this latter conventional system after removal of the
implanted device, that was carried out in an outpatient
setting, under local anesthesia, and no further annoyance for
them. Even the four subjects who had their invisible device
EsteemVR explanted were not regretting their previous
implanting surgery that had allowed—although temporar-
ily—to improve their quality-of-life and were, after the
explant, returning to a favorable hearing condition either
with an ossicular reconstruction (two cases) or with a coch-
lear implant (two cases).
For all the implanted devices, a significantly better hear-
ing performance has been shown in comparison with the
unaided condition. From this finding, one would have
expected a homogenous positive trend in the patient’s satis-
faction rate, but the results from the different questionnaires
QUALITY OF LIFE
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ESTEEM BAHA
%
VAS>6
VAS>8
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ESTEEM BAHA
sc
or
e
QUALITY OF SOUND 
ch-AIDED
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VAS in pBCI vs Esteem
Figure 6. VAS comparison in quality of sound and life between non-SSD percutaneous BCI; pBCI (21 patients) and Esteem (26 patients). The improvement of quality
of sound in respect to the c-HA condition is highly significant with both devices (p¼ .000 040 7 for pBCI; p¼ .000 000 035 for Esteem) without differences between
the two. A higher improvement of the quality-of-life was found for the Esteem subjects in comparison to the pBCI ones, when considering VAS scores >8 (p¼ .000
074 04).
50%
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26% 43%57%
−805%
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0,00000000058
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0,000000010
APHAB in pBCI vs Esteem
Figure 7. APHAB total and partial scores between non-SSD percutaneous BCI; pBCI (21 patients) and Esteem (26 patients). Both aided conditions were found signifi-
cantly improved in respect to the cHA situation (Esteem, p¼ 0.000 000 000 58; pBCI, p¼ 0.000 000 010). Partial APHAB scores showed an improvement for all the
sub-domains, except for ‘aversiveness’. A statistical difference in favor of the pBCI was found in the sub-domain ‘reverberation’. pBCI: percutaneous bone conductive
implant; BN: background noise; AV: aversiveness; EC: ease of communication; RV: reverberation.
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have clearly shown that many differences do exist among
the devices taken into consideration, presumably related to
the specificity of each surgical procedure. Modality of anes-
thesia, duration of hospitalization, and post-operative course
with the complication rate are surely of considerable import-
ance in this regard. The GBI questionnaire used in the pre-
sent study is specifically related to the health changes
generated by a surgical procedure, by measuring them as a
whole as well as partial scores (general, physical, and social
health changes). The total GBI score showed a greater
improvement of the VSB, which resulted as significant only
in respect to the EsteemVR , but not to the other devices taken
into consideration (percutaneous and transcutaneous BCI).
Coming to the partial GBI scores, the greatest score for
social health was registered in pBCI, while for physical
health and general health, the transcutaneous BCI
BonebridgeVR and VSB and BonebridgeVR were shown to pre-
vail, respectively. From these findings it is possible to
assume that the effect on health is not related to esthetic or
functional features, but mainly to some surgical aspects
(duration and post-operative course, for example).
A deeper insight within the overall results of the present
study has been targeting specific issues that regarded the
comparison between:
a. cHA-aided vs I-aided situations;
b. pBCI vs AMEI in mixed hearing loss; and
c. an invisible device (EsteemVR ) vs the most unesthetic
device (percutaneous BCI).
cHA-aided vs I-aided situations
Although the study group was composed of subjects who
were glad to be enrolled, whilst other subjects, including
some with negative features (explanted, not available, etc.)
were not part of it, all the devices implanted recorded—via
the VAS scale for quality of hearing—a statistically better
auditory condition in comparison with that achieved by cHA.
For AMEI, the higher score was found to be for the VSB in
respect to the EsteemVR , which can be explained with the
prevalent gain at high frequencies that can be provided by the
VSB actuator [20]. When considering the quality-of-life, it
has been arbitrarily decided to distinguish two different score
ranges of positivity: one limited to 6, indicative of a good
achievement, the other extended up to 8, that should regard
an optimal outcome. So, while VAS data up to 6 were reached
by all the devices, when considering those reaching 8, the
advantage of having an invisible, fully-implantable device,
such as the EsteemVR , has clearly emerged.
For each device, the comparison between the activated
implant and the conventionally-aided situation showed a sig-
nificant improvement of the total APHAB score, with the
worst score gain obtained by the EsteemVR . For reverberation,
in addition, a better score was found in pBCI than in the
EsteemVR , presumably due to the lack of alternative, reliable
rehabilitation means for the mixed hearing loss cases that
eventually received a pBCI. Similar findings were also
obtained from the APHAB questionnaire in which the sub-
domain aversiveness was the only one that did not show an
improvement.
pBCI vs round-window vibrant soundbridge in mixed
hearing loss
The rehabilitation of mixed hearing loss, in presence of a
BC threshold <40 dB, still represents a challenge for the
otologists that may theoretically choose between a BCI,
either percutaneous or transcutaneous, and an AMEI
coupled to the ossicular remnants or to the round window
membrane. Part of our study group was actually formed by
several individuals with this type of hearing loss, who
received either of the implants and could, therefore, be com-
pared. At APHAB questionnaire, very similar and better
results were found in both situations in comparison with a
cHA, as total and partial scores. However, as shown by the
VAS on quality of sound, the outcome with the RW-VSB
device was much higher and more appreciated, presumably
due to the selective amplification that this device may pro-
vide at the high frequency level.
pBCI vs esteem
The last issue that it was decided to explore was the compari-
son of patient’s appreciation between two theoretically
extreme situations in implanting surgery: one that ends up
with an invisible device (EsteemVR ) against another one that
retains a visible component anchored to a penetrating skin
trough (percutaneous or pBCI). When assessed by question-
naires, somewhat surprising results were observed. It was, in
fact, shown that the quality of sound at VAS was pretty simi-
lar between the two devices, although the starting auditory
level was obviously different, being mostly conductive for the
BCI and sensorineural for the EsteemVR . Also, the changes of
health status occurring after the surgical application (GBI
score) indicated to give preference to the pBCI with statistical
significance, although the sub-domain of physical health was
prevailing for the EsteemVR , presumably owing to the absence
of any external component. When applying the APHAB
questionnaire to this comparison, instead, no differences
were shown between the two devices, even though the rever-
beration gain was statistically better for the pBCI.
The present survey has provided some insight into the
role played by auditory implantable devices for improving
quality-of-life in all subjects who have benefited of this sur-
gical solution in terms of hearing improvement. All the
devices provided a better quality-of-life in respect to conven-
tional hearing aids, but the esthetic factor was not the most
important role for it. In fact, when experiencing less invasive
and shorter surgical procedures, such as is the case for a
percutaneous BCI, the patients would retain a more positive
experience and, therefore, receive a greater improvement in
quality-of-life.
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